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Abstract Transfection of neurones with an adenoviral vector
(Ad) expressing high levels of hsp70i was shown to protect
primary hippocampal cultures from heat stress. To investigate
one of the molecular mechanisms which may underlie hsp70i’s
neuroprotective effects we measured luciferase activity in the
presence and absence of hsp70i following heat or chemical
inactivation. Luciferase activity was recovered to 80% of control
levels in the presence of recombinant hsp70i in vitro. Luciferase
activity was also maintained in primary hippocampal neurones
exposed to a denaturing stress if transfected with Ad-hsp70i.
These results support the hypothesis that hsp70i protects
neurones from stress by interacting with cytosolic proteins and
thereby protecting them from inactivation.
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1. Introduction
Cells respond to a sublethal heat shock and several other
forms of stress by suppressing normal cellular transcription
and translation and at the same time activating the transcrip-
tion of potentially protective heat shock proteins (hsps). The
most abundant of these proteins and the most intensely
studied are the constitutively expressed and highly inducible
forms belonging to the 70 kDa, hsp70 family. The molecular
functions of the constitutively expressed members of the hsp70
family (hsc70s) have been investigated extensively in both eu-
karyotic and prokaryotic organisms [1,2]. In prokaryotes
hsc70 has been shown to increase the yield of native protein
in cells either by directly binding and renaturing proteins or
by regulating processes to degrade non-native or non-func-
tional proteins [3^7]. In eukaryotes they have multiple func-
tions, acting primarily as intracellular molecular chaperones
and as clathrin uncoating enzymes [8]. The inducible forms of
hsp70 have been less well studied, though they share a high
degree of sequence homology with hsc70 proteins and are
therefore also thought to act as molecular chaperones.
Hsp70s have been shown to be monomeric proteins consist-
ing of three domains. An N-terminal domain is the most
highly conserved and functions as an ATPase while a C-ter-
minal domain is less highly conserved and is of unknown
function. The third domain lies between the N- and C-termi-
nal domains and plays a pivotal role in peptide binding, trans-
port of proteins through intracellular membranes and regula-
tion of the heat shock response [9,10].
Studies of the mammalian brain have shown that induction
of hsp70i occurs in animals following epilepsy, ischaemia,
trauma, hyperthermia and exposure to excitotoxins [11^13].
Hsp70i immunoreactivity in the hippocampus has been shown
to identify neurones destined to survive a transient ischaemic
insult with sequential appearance of staining in dentate gran-
ule cells and CA3 pyramidal neurones while vulnerable CA1
neurones showed minimal accumulation of hsp70i [14]. Ex-
periments have also shown that induction of a heat shock
response can protect cultured neurones from heat, excitotoxic
and ischaemic stress [15^17]. In this study we have investi-
gated the mechanism by which the neuroprotective e¡ects of
hsp70i may be brought about taking advantage of a highly
e⁄cient adenoviral expression system. Using ¢re£y luciferase
as reporter protein we have conducted in vitro refolding ex-
periments and investigated the mechanism by which hsp70i
interacts with other proteins in a living cell to prevent dena-
turation following a stress.
2. Materials and methods
2.1. Preparation of rat primary hippocampal cell cultures and
Ad infection
Hippocampi were dissected from embryonic rat brains (E15^17)
and digested in Hanks’ balanced salt solution (HBSS) without calcium
and magnesium with 1 mg/ml trypsin for 40 min at 37‡C. The cells
were washed three times in HBSS and triturated in 500 Wl of Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) supplemented with 5% B-27
supplement (Gibco BRL), 2% inactivated foetal calf serum (Sigma),
glutamine (100 mM), penicillin (100 U/ml) and streptomycin (100 Wg/
ml) (this medium is DMEMS). After trituration 2 ml of DMEMS was
added and 50 Wl of the suspension aliquoted onto 10 mm wells which
had previously been coated with polylysine (0.1 mg/ml). After tritu-
ration 500 Wl DMEMS was added to each well and the ¢nal cell
concentration was 1U106 cells/well. The plates were incubated in
5% CO2 at 37‡C. Cytosine arabinoside (2 Wg/ml medium) was added
to each well 48 h after plating. Primary hippocampal cultures were
transfected at a multiplicity of infection (MOI) of 100, 7 days after
plating with the Ad vectors.
2.2. Heat shock and trypan blue staining
Primary hippocampal neurones were heat shocked at 45‡C for 20
min. The cells were allowed to recover at 37‡C for 48 h. After this
period the number of dead cells was determined by trypan blue stain-
ing of the cultures. The medium was removed and cells were washed
once with phosphate bu¡ered saline (PBS). Cultures were then incu-
bated in trypan blue solution (0.2%) for 5 min and then observed
under phase contrast microscopy. Cells were identi¢ed as viable by
the absence of blue staining within the cell body.
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2.3. Ad vector construction
Recombinant, E1-deleted, Ad constructs were produced according
to standard techniques [18^20]. The human hsp70i gene [21] was
cloned in the Ad transfer vector pXCXCMV under the control of
the human cytomegalovirus major (CMV) IE promoter enhancer frag-
ment (663 bp of pcDNA 1; Invitrogen), followed by a bovine growth
hormone poly A tail. The ¢re£y luciferase reporter gene from pGL
vector (Promega) was also inserted into a second pXCXCMV. Re-
combinant viruses were generated by homologous recombination in
HEK 293 cells [22] with the helper plasmid pJM17 [23] to create Ad-
hsp70i and Ad-luc. Recombinant vectors were grown to high titres
and puri¢ed by standard techniques [18]. The construction of the
regulatable enhanced green £uorescent protein adenoviral construct
(Ad-EGFP) has been described previously [19]. Viral titres were de-
termined by plaque assay. In addition Ad-lacZ an Ad encoding the
lacZ gene expressing L-galactosidase and Ad-0 a virus with no insert
were also used in this study and have been described before [24].
Experiments were conducted at an MOI of 100 which results in ap-
proximately 50% of cells being transfected.
2.4. RT-PCR analysis of primary hippocampal neuronal cultures
RNA was isolated (Stratagene) from primary hippocampal cultures
and cDNA prepared using AMV reverse transcriptase (Promega).
PCR was then performed with primers speci¢c to human hsp70i:
sense strand 5PC3P : GCGGAGAAGTACAAAGCG, antisense
strand 5PC3P : CCCTCCCTTGGGACCCTGA. Reaction products
were then separated on a 1% agarose gel and stained with ethidium
bromide.
2.5. Western blot analysis
Twenty-four hours post Ad transfection, medium was removed and
protein was extracted from the primary hippocampal cultures. The
lysate was cleared of cell debris and the protein separated with 10%
SDS-PAGE. As standard proteins Bio-Rad rainbow marker was used.
The separated proteins were then transferred to a nitrocellulose mem-
brane and hsp70i was detected using anti-hsp70i monoclonal antibody
(Stressgen). Blots were then processed using a biotin conjugated sec-
ondary antibody (Sigma) and incubated with ExtraAvidin-Alkaline
phosphatase (Sigma). The hsp70i bands were visualised using NBT/
BCIP solution (Sigma).
2.6. Luminometric assay
To detect luciferase enzyme activity in vitro and in vivo, a lumino-
metric assay was used. In vitro enzyme activity was measured by
adding 20 Wl of luciferase (0.5 mg/ml) to 100 Wl of test substrate
(Promega). For in vivo assays neuronal cells were washed in PBS
once and lysed in 60 Wl cell lysis bu¡er (Promega). Cells were removed
from the well and centrifuged at 12 000Ug for 1 min. 20 Wl of the
clear supernatant was added to 100 Wl of test substrate. The relative
light units of the enzymatic reaction were determined in a Bio Orbit
1253 Luminometer at V= 562 nm.
2.7. In vitro luciferase activity assay
To determine luciferase reactivation the enzyme was diluted in bu¡-
er A (40 mM Tris-HCl pH 7.7, 2 mM EDTA, 5 mM MgCl2, 5m M
ATP, 5 mM DTT (DL-dithiothreitol)). For deactivation 2 mg/ml lu-
ciferase was incubated in bu¡er A plus 7 M GdmCl for 2 h at 25‡C. A
second method of deactivation was to heat shock 2 mg/ml luciferase
in bu¡er A for 15 min at 41‡C. After complete deactivation of lu-
ciferase 10 Wl of the protein solution was diluted into bu¡er A (1:100)
with or without 20 Wg/ml hsp70i. Luciferase reactivation kinetics were
measured (described above) immediately after mixing.
2.8. In vivo luciferase activity assay
To determine hsp70i and luciferase activity within neurones hippo-
campal primary cultures incubated at 37‡C and in 5% CO2 were
infected with Ad-luc plus Ad-hsp70i or Ad-luc plus Ad-lacZ. Forty-
eight hours after viral transfection with two Ads, hippocampal neuro-
nes were heat shocked in an incubator at 42‡C, 5% CO2 for 30 min
and then returned to the 37‡C incubator. After the heat shock samples
were taken at various time points and luciferase activity monitored.
2.9. MTT assays
This assay estimates the metabolic activity of cells by measuring the
mitochondrial-dependent conversion of the tetrazolium salt, MTT, to
a coloured formazan product. At each time point 20 Wl of MTT (5
mg/ml in PBS) was added to each well of primary hippocampal neu-
rones and incubated for 2 h at 37‡C. The medium was then carefully
aspirated and 100 Wl of acidi¢ed isopropanol added to solubilise the
coloured formazan product deposited in the viable cells. Absorbance
was read at 550 nm on a scanning multiwell spectrophotometer after
agitating the plates for 5 min on a shaker.
3. Results
To con¢rm that the Ad-hsp70i virus could mediate the ex-
pression of hsp70i mRNA and protein, RT-PCR and Western
blot analysis were used respectively. RT-PCR analysis was
carried out on primary hippocampal cultures transfected
with Ad-hsp70i, Ad-0 or Ad-lacZ. Transfection with Ad-
hsp70i (but not transfection with Ad-lacZ or Ad-0) mediated
the transcription of hsp70i mRNA in primary hippocampal
cultures (Fig. 1A). Western blot analysis using an anti-hsp70i
monoclonal antibody was used to con¢rm Ad mediated ex-
pression of hsp70i protein in hippocampal neurones (Fig. 1B).
Prior to carrying out the reactivation and neuroprotection
studies, the e⁄ciency of neuronal transfections was estimated
using Ad reporter constructs expressing enhanced green £uo-
rescent protein (Ad-EGFP) and L-gal (Ad-lacZ). Fig. 2A
shows that 6 75% of cells could be transfected when primary
hippocampal cultures were transfected with the Ad-EGFP (or
Ad-lacZ) construct at an MOI of 200. Transfected at MOIs of
100 resulted in 40^50% of cells being transfected [19]. Trans-
fection of cells by Ads entails the binding of the vector to cell
surface receptors (predominantly to the Coxsackie adenoviral
receptor) followed by endocytosis. The rate of cell transfection
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Fig. 1. Detection of hsp70i mRNA and protein following the trans-
fection of primary hippocampal neurones with Ad-hsp70i. A: RT-
PCR analysis to detect speci¢c induction of hsp70i mRNA in pri-
mary hippocampal neurones transfected with Ad-hsp70i. Lane 1:
untransfected primary hippocampal cultures; lane 2: positive control
employing a hsp70i encoding plasmid in the PCR; lane 3: primary
hippocampal cultures transfected with the Ad-hsp70i virus; lane 4:
primary hippocampal cultures transfected with Ad-0 and Ad-lacZ
virus respectively. B: Western blot demonstrating the speci¢c induc-
tion of hsp70i in primary rat hippocampal neurones transfected
with Ad-hsp70i. Lane 1: cells without adenovirus infection; lane 2:
infection with Ad-0; lane 3: infection with Ad-hsp70i; lane 4: rain-
bow marker for SDS-PAGE.
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Fig. 2. Protection of primary hippocampal neurones from heat shock following transfection with an Ad expressing hsp70i. A: A £uorescent
photomicrograph showing the high number of primary hippocampal neurones transfected with the AdEGFP construct. B and C: Trypan blue
staining of cells transfected with the Ad-lacZ and Ad-hsp70i vectors respectively.
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is therefore related to the number of virus particles available
to bind to its receptors and not to the gene encoded by the
construct. In this study to ensure that the same amount of
each viral construct was added, the titre of the Ad-hsp70i and
Ad-lacZ vectors was measured by plaque assay beforehand
and each was diluted to 4.5U109/plaque forming (PFU)
units/ml.
To investigate the ability of Ad-hsp70i to mediate neuro-
protective e¡ects primary rat hippocampal cultures were
transfected with either Ad-hsp70i or an Ad-0 vector and
then exposed to a sub-lethal heat shock. Cultures transfected
with the Ad-hsp70i construct showed a signi¢cantly higher cell
viability (94% þ 6.0, mean þ S.E.M.) than those transfected
with Ad-0 (60% þ 5.0) after heat shock as assessed by trypan
blue exclusion assays (Fig. 2). The number of dead cells was
greatly underestimated in the Ad-0 transfected cultures as
many of the cells had become detached from the surface of
the well and these were not counted. Cultures transfected with
the constructs not exposed to the heat shock had identical cell
viabilities (data not shown).
The ability of hsp70i to increase the rate of reactivation of
denatured proteins was studied in vitro and in vivo using
luciferase as a reporter protein. Hsp70i’s stabilising activity
was tested by luminometrically monitoring the enzymatic ac-
tivity of denatured luciferase in the presence or absence of
recombinant hsp70i protein. The results showed that heat or
GdmCl inactivated luciferase (data not shown) could be re-
stored to approximately 70% of its former maximal activity in
the presence of hsp70i (Fig. 3A). Reactivation of previously
heat denatured luciferase was three times higher with hsp70i
protein added than without the chaperone (Fig. 3B). It was
not possible to calculate the respective rate constants as nei-
ther reaction followed ¢rst or second order kinetics. To de-
termine whether overexpression of hsp70i could also prevent a
decrease in luciferase activity in vivo primary hippocampal
neurones were transfected with Ad vectors expressing hsp70i
and luciferase and then exposed to a heat stress. In control
experiments Ad-hsp70i was replaced with an Ad expressing L-
galactosidase. The fact that neuronal cells can be successfully
transfected by two Ad vectors at the same time has previously
been shown by Harding et al. [19,20]. Higher levels of lucifer-
ase activity were observed in cells transfected with Ad-hsp70i
plus Ad-luc when compared to cells transfected with Ad-luc
plus Ad-lacZ (Fig. 4). In the presence of Ad-hsp70i luciferase
activity did not signi¢cantly decrease and remained at approx-
imately 80% of maximum activity for at least 2 h after heat
shock. In contrast cells transfected with Ad-luc plus Ad-lacZ
showed a decrease in luciferase activity with time and 2 h
following the heat shock luciferase activity was no longer
detectable. The luciferase activity prior to heat shock was
identical in Ad-hsp70i transfected and Ad-lacZ transfected
cultures and set as 100%.
MTT assays were also carried out to compare the relative
toxicities of the transfection and heat shock procedures. These
experiments clearly showed that 24 h after heat shock (and 48
h after transfection) neurones which were transfected with Ad-
hsp70i and then exposed to a heat shock had signi¢cantly
higher mitochondrial activity (as estimated by the MTT assay)
than cells transfected with Ad-EGFP or Ad-lacZ and then
heat shocked. MTT values þ S.E.M. were; Ad-hsp70+heat
shock (HS) = 3.3 þ 0.075; Ad-EGFP+HS = 2.6 þ 0.1; Ad-
lacZ+HS = 2.65 þ 0.05. P6 0.0001 when Ad-hsp70+HS was
compared to the Ad-EGFP or Ad-lacZ experiments by Stu-
dent’s t-test.
4. Discussion
This and other recent studies [19,20,24,25] have shown that
E1-deleted type 5 adenoviruses are a powerful new molecular
tool which should greatly facilitate studies into neuronal gene
function. The data in this investigation show that Ad mediates
the highly e⁄cient transfection of primary hippocampal neu-
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Fig. 3. In vitro reactivation kinetics of (A) GdmCl denatured lucif-
erase (b) with and (a) without hsp70i; (B) thermally denatured luci-
ferase (b) with and (a) without hsp70i. Relative light units refer to
native luciferase diluted and assayed in the same way as denatured
samples.
Fig. 4. In vivo protection of luciferase in rat hippocampal primary
cultures after heat treatment. Open symbols: luciferase activity in
cells transfected with Ad-luc and Ad-lacZ. Closed symbols: lucifer-
ase activity in cells transfected with Ad-luc and Ad-hsp70i. Relative
light units refer to 100% luciferase activity before heat treatment.
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rones, and that Ad mediated overexpression of hsp70i can
enhance the survival of neurones following exposure to severe
heat stress. These results support the ¢ndings of Rodorf et al.
[15] and Lowenstein et al. [17] who showed that exposure of
primary neuronal cultures to a sub-lethal elevation in temper-
ature induced hsp expression and protected these cells against
a subsequent stress. We have also shown that recombinant
hsp70i protein alone can mediate the reactivation of dena-
tured luciferase in vitro. Furthermore, Ad mediated luciferase
enzymatic activity in neurones is only maintained at high lev-
els following a heat stress when the cells are also co-trans-
fected with Ad-hsp70i. Following heat stress, denatured
protein such as luciferase may aggregate and/or bind non-
speci¢cally to cellular proteins interfering with their normal
cellular function [26]. Our results suggest that hsp70i is inter-
acting directly with denatured luciferase and supports the
hypothesis that hsp70i may protect cells against stress which
results in protein denaturation and aggregation by allow-
ing them to stabilise and reactivate partially denatured pro-
teins.
Recent work has shown that some hsc70 proteins may be
directed to di¡erent protein substrates by interacting with
proteins known collectively as DnaJs or hsp40s [27,28]. Sev-
eral eukaryotic DnaJ homologues have now been isolated
suggesting that DnaJ proteins may participate in at least
some of the reactions catalysed by eukaryotic hsp70 family
members [29]. Cheetham et al. [30] isolated a human alterna-
tively spliced DnaJ homologue (hsj1a and hsj1b) and showed
that the isoforms were stress inducible and located exclusively
in the brain. Another mammalian DnaJ homologue isolated
from HeLa cells, hsp40, has been shown to be highly stress
inducible and accumulates in the nucleus and nucleolus during
stress, a pattern similar to that seen for hsp70i. In addition
hsp40 was co-localised with hsc73 in heat shocked HeLa cells.
These results were interpreted as suggesting that hsp40 and
hsc70/hsp70i may act together to prevent nascent proteins
from becoming abnormally folded and may also prevent pro-
tein aggregates from accumulating [31,32]. A more recent
study has shown that the overexpression of HSDJ (a hsp40
chaperone protein which interacts with hsp70 proteins to me-
diate protein refolding and translocation) prevented the accu-
mulation of ataxin-1 in a transgenic mouse model of spino-
cerebellar ataxia type 1 (SCA1) [33]. These ¢ndings suggest
that increasing the expression of DnaJ like proteins in vivo
may also facilitate the neuroprotective e¡ects of hsp70i. In-
deed, it may be that hsp70i acts to some degree with consti-
tutively expressed DnaJ proteins in vivo to mediate its pro-
tective e¡ects. The presence of insoluble protein aggregates,
such as those found in SCA1, is a hallmark of a number of
other neurodegenerative diseases, e.g. Lewy bodies in Parkin-
son’s disease, neuro¢brillary tangles and amyloid plaques in
Alzheimer’s disease. The mechanism which leads to protein
aggregation is unknown but it is possible that the disease itself
is caused by abnormal protein-protein interactions which
eventually results in the accumulation of insoluble protein
aggregates. Alternatively, it may be that aberrant insoluble
proteins are produced during the disease progress due to al-
tered protein metabolism. The data presented in this study
suggest that the overexpression of chaperone molecules in
neurones stabilises and maintains the function of intracellular
proteins and thus slows or prevents inactivation due to stress.
Therefore, the strategy of inducing the expression of speci¢c
chaperone molecules to delay the onset of neurodegenerative
disease, especially those characterised by the accumulation of
abnormal proteins should be investigated.
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